Skip to main content

Table 3 Clinical outcomes in acute heart failure patients with or without acute coronary syndrome

From: Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry)

 

Overall

n = 2609

ACS-AHF

n = 725 (27.79 %)

NACS-ACS

n = 1884 (72.21)

P value

Hospital course and outcomes

 Recurrent CHF, n (%)

816 (31.3)

251 (34.6)

565 (30.0)

0.022

 Overall shock, n (%)

228 (8.7)

94 (13.0)

134 (7.1)

<0.001

  Cardiogenic, n (%)

169 (74.1)

73 (77.7)

96 (71.6)

0.132

  Non-cardiogenic, n (%)

22 (9.6)

11 (11.7)

11 (8.2)

  Mixed, n (%)

37 (16.2)

10 (10.6)

27 (20.1)

 VT/VF requiring therapy, n (%)

110 (4.2)

45 (6.2)

65 (3.4)

0.002

 AF requiring therapy, n (%)

156 (6.0)

25 (3.4)

131 (6.9)

<0.001

 Sepsis, n (%)

196 (7.5)

68 (9.4)

128 (6.8)

0.025

 Major bleeding, n (%)

38 (1.5)

14 (1.9)

24 (1.4)

0.209

 Stroke/TIA, n (%)

48 (1.8)

23 (3.2)

25 (1.3)

0.002

 Hospital stay, days; mean ± SD

12.3 ± 14.6

13.1 ± 15.38

12.0 ± 14.3

0.083

 Hospital stay, days; median (IQR)

8.0 (9.0)

8.0 (10.0)

8.0 (9.0)

0.111

All-cause mortality

 Hospital, n (%)

170 (6.5)

64 (8.8)

106 (5.6)

0.003

 1 month, n (%)

212 (8.1)

73 (10.1)

139 (7.4)

0.044

 1 year, n (%)

509 (19.5)

147 (20.3)

362 (19.2)

0.568

 2 years, n (%)

615 (23.6)

171 (23.6)

444 (23.6)

0.680

 3 years, n (%)

635 (24.3)

175 (24.1)

460 (24.4)

0.671

  1. Abbreviations: ACS-AHF acute coronary syndrome with acute heart failure, ACS-NASC no acute coronary syndrome with acute heart failure, VT ventricular tachycardia, VF ventricular fibrillation, AF atrial fibrillation, TIA transient ischemic attacks